Imugene Licenses Cd19 Oncolytic Virus From City of Hope to Turn Car T Therapy Against Solid Tumors

SYDNEY & DUARTE, Calif.--(BUSINESS WIRE)--City of Hope and Imugene have entered into a licensing agreement for the patents covering a novel combination immunotherapy.

Click to view original post